Last quarter (Q0 0), Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's total revenue was $2.69B, an increase of 72.71% from the same quarter last year. In Q0, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's net income was $132.83M. See Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 8.25B	$ 8.25B	$ 6.91B	$ 6.60B	$ 6.99B	$ 6.36B
Cost of Revenue	$ 4.96B	$ 4.96B	$ 4.15B	$ 4.03B	$ 4.05B	$ 3.72B
Gross Profit	$ 3.29B	$ 3.29B	$ 2.76B	$ 2.58B	$ 2.95B	$ 2.64B
Operating Expense	$ 2.57B	$ 2.57B	$ 2.14B	$ 1.98B	$ 2.38B	$ 2.16B
Operating Income	$ 723.34M	$ 723.34M	$ 613.18M	$ 595.93M	$ 576.09M	$ 476.16M
Net Non Operating Interest Income Expense	$ 42.21M	$ 42.21M	$ 44.94M	$ 24.98M	$ 6.65M	$ -3.67M
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ 980.19M	$ 980.19M	$ 872.81M	$ 768.06M	$ 743.15M	$ 640.63M
Tax Provision	$ 106.93M	$ 106.93M	$ 85.93M	$ 88.40M	$ 107.79M	$ 72.84M
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ 861.79M	$ 861.79M	$ 769.14M	$ 661.70M	$ 625.57M	$ 561.68M
Basic EPS	$ 1.12	$ 1.12	$ 1.00	$ 0.86	$ 0.81	$ 0.73
Diluted EPS	$ 1.11	$ 1.11	$ 1.00	$ 0.86	$ 0.81	$ 0.73
Basic Average Shares	$ 3.08B	$ 769.46M	$ 769.14M	$ 769.42M	$ 772.31M	$ 769.42M
Diluted Average Shares	$ 3.11B	$ 776.39M	$ 769.14M	$ 769.42M	$ 772.31M	$ 769.42M
Dividend Per Share	$ 0.50	$ 0.50	$ 0.30	$ 0.30	$ 0.22	$ 0.20
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ 0.96	$ 0.82	$ 0.78	$ 0.71
Reported Normalized Diluted E P S	$ ―	$ ―	$ 0.96	$ 0.82	$ 0.78	$ 0.71
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 7.53B	$ 7.53B	$ 6.29B	$ 6.01B	$ 6.43B	$ 5.88B
Net Income From Continuing And Discontinued Operation	$ 861.79M	$ 861.79M	$ 769.14M	$ 661.70M	$ 625.57M	$ 561.68M
Normalized Income	$ 902.57M	$ 912.83M	$ 774.21M	$ 655.03M	$ 580.65M	$ 556.45M
Interest Expense	$ 8.69M	$ 10.27M	$ 2.94M	$ 6.66K	$ 4.89M	$ 11.38M
EBIT	$ 990.46M	$ 990.46M	$ 875.74M	$ 768.06M	$ 748.04M	$ 652.01M
EBITDA	$ 990.46M	$ 1.11B	$ 991.28M	$ 878.91M	$ 846.19M	$ 728.16M

Currency in USD

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing